Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken. Watch this short video to learn why!

FDA Class II Special Controls for Herpes Simplex Virus CNS Diagnostic Assays

$9.99

Stay ahead in medical device regulation with this targeted course on the FDA’s classification of herpes simplex virus (HSV) nucleic acid-based assays for central nervous system infections. Gain actionable insights into the specific special controls required for Class II devices, from design and clinical validation to quality assurance and regulatory documentation. Learn how these controls streamline market access while ensuring device safety and effectiveness, making this training essential for anyone involved in the development, testing, or regulatory submission of diagnostic assays.

In this course you will learn the following:
* Understand the classification process and criteria for the herpes simplex virus nucleic acid-based assay.
* Identify the special controls required for compliance.
* Recognize the impact of this classification on regulatory burdens and patient access to innovative devices.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year.  At the end of the one year term, the course will be set to “inactive”. 

Why This Course is Important
Without this course, you may overlook critical FDA requirements for HSV CNS diagnostic devices, risking compliance gaps and delayed market access.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Immunology and Microbiology Devices; Classification of the Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections.

Key regulatory references include:

Course SKU
FR-25-1407-1